Medtronic Wins TAVR Patent Infringement Appeal, Avoids $106.5M Payout

Federal Court of AppealsSupport Medtronic, Overturn 2023 AdditionState Jury Rules (Medtronic's TAVR Product Series InfringementColibri Heart ValveThe two patents require Medtronic.ToColibri Heart ValvePay $106.5 Million for Patent Infringement Compensation）。

Review of the Infringement Case

In 2019,Colibri Heart ValveColibri Heart Valve, LLC Accuses Medtronic of Infringing Its Patent for Replacement Heart Valves. The lawsuit claims that Medtronic's CoreValve, CoreValve Evolut R, CoreValve Evolut Pro, and CoreValve Evolut Pro+ series infringe on two of its patents.

Colibri Heart ValveCause of Action: The doctor's use of Medtronic's TAVR infringes uponColibri Heart ValveThe patent, which covers a method for controlling the deployment of self-expanding artificial heart valves.

According toColibri Heart ValveDescription: ItsCEO Joseph HornMet with some managers of Medtronic in May 2014 - according to the confidentiality agreement - to discussColibri Heart ValveThe successful implementation of the TAVR product in patients, followed by a teleconference with Medtronic in July 2014,And sent a PowerPoint presentation on the patent to Medtronic in 2018.。

Through the appellate process, the Federal Court of Appeals overturned the original ruling this week. The court held that Medtronic is entitled to a judgment of "non-infringement of the '294 patent" as a matter of law, thereby vacating the district court’s prior dismissal of that judgment. This vacatur rendered the remaining issues on appeal moot.

A panel of three judges pointed out in the ruling that the judge of the original trial court did not confirm whether Medtronic had actually infringed.

Next, I don't know.Colibri Heart ValveWhether to continue collecting evidence and appeal.

Colibri TAVI SystemIt is the only truly thin transcatheter aortic heart valve, which uses dry tissue technology to achieve a pre-installed, pre-crimped, and pre-loaded heart valve.

ColibriThe manufacturing process offers significant operational, quality, and cost advantages compared to traditional "wet" technology, as it ensures controlled and precise valve crimping and placement on the delivery system, and eliminates the need for on-site cleaning, installation, crimping, and loading of the valve before use.

Colibri TAVI SystemValveIt is formed from three separate proprietary "dry" porcine pericardium pieces, utilizing a unique folding method. The valve's folded design reduces the amount of material in the frame and minimizes the number of sutures required to manufacture the valve.Colibri TAVI SystemValveUnique design willThe number of sutures has been reduced to less than 200, while enhancing durability and functionality.Colibri TAVI SystemValveUnique DesignAllows unprecedented profile reduction, minimizing the profile of the curled valve while enabling superior valve efficiency and reduced cardiac load.